ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0187

Advancing Health Equity with Lupus Stakeholders to Close Care Gaps and Disparities

Shalvi Parikh1, Monica Messina1, Shivani Garg1, Sancia Ferguson2, Edmond Ramly3, Andrea Gilmore-Bykovskyi4, Katrina Phelps5 and Christie M. Bartels6, 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin, Madison, WI, 3Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin School of Medicine and Public Health, Madison, WI, 5School of Nursing, University of Wisconsin-Madison, Madison, WI, 6University of Wisconsin, School of Medicine and Public Health, Madison, WI

Meeting: ACR Convergence 2023

Keywords: Disparities, Health Services Research, Qualitative Research, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0176–0195) Healthcare Disparities in Rheumatology Poster I: Lupus

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) care and outcomes are associated with significant racial and socioeconomic disparities in the US, particularly among young Black and Hispanic/Latina women. We previously identified disparities, including gaps in SLE retention in care (defined as a rheumatology clinic visit or lupus-specific lab test every 6 months) and hydroxychloroquine (HCQ) use and adherence. We sought to address these modifiable gaps in SLE care by adapting intervention approaches from other chronic diseases. We engaged patients and healthcare community stakeholders to garner input to prioritize actionable steps and intervention strategies to reduce disparities in SLE retention in care and HCQ use to improve outcomes and equity.

Methods: We recruited SLE experts and stakeholders, including patients, providers, and advocates (State Public Health Department, Lupus Foundation, and the American College of Rheumatology) to adapt intervention strategies from other chronic conditions to be tested in SLE. The patient advisory board (PAB; n=8) included patients with SLE representing racial, geographic, age, and sex diversity (Figure 1). PAB insights were presented to a healthcare advisory board (HAB; n=12) of 6 rheumatologists, 2 rheumatology nurses, 2 primary care providers, and 2 patient advocates (Figure 1). The HAB reviewed prior findings on SLE care gaps and evaluated proven interventions for a pilot. Each group had 3 virtual meetings of 90 minutes (total=6) scheduled to be alternating and iterative. Sessions were audio-video recorded and analyzed using direct content analysis with NVivo software (Melbourne, AU).

Results: The PAB discussed several barriers to SLE retention in care and HCQ, categorized as: labs, visits, and medication adherence (see Table 1 quotes and meta-themes). Facilitators were similarly identified and grouped (Table 1). The main evidence-based interventions considered were electronic health record (EHR) workbench decision support (e.g., HIV FastTrack) that cues staff action upon missed visits and labs; shared decision making; and patient navigators (Table 2). All HAB members and 5 of 8 PAB members supported implementing EHR workbench decision support. PAB and HAB members also suggested including a patient navigator as a supplement to answer patient questions and address challenges in scheduling, medication dosing, and cost barriers, among others. Among HAB members, 8 of 12 recommended EHR workbench decision support as high-impact and low-effort; while 7 of 12 rated patient navigator as high-impact but high-effort. Many discussed that the two could be complementary, recommending EHR workbench decision support first, followed by patient navigator. Indicators for additional support recommended by HAB members were social determinants of health, missed labs or clinic visits, and frequent acute care.

Conclusion: Patient and healthcare stakeholders endorsed implementing EHR workbench decision support, potentially followed by a patient navigator, to reduce disparities and care gaps in SLE. An external advisory board of national SLE leaders is advising scalability for a larger study, and the findings will inform addressing key gaps and unique factors in SLE.

Supporting image 1

Figure 1. Focus Group Demographics and Meeting Schedule

Supporting image 2

Table 1. Selection of Patient Identified Barriers (B) and Facilitators (F) to Labs, Visits, and Medication Adherence with List of Predominant Meta-themes

Supporting image 3

Table 2. Patient and Healthcare Members’ Reactions to Proposed Evidence-Based Interventions


Disclosures: S. Parikh: None; M. Messina: None; S. Garg: None; S. Ferguson: None; E. Ramly: None; A. Gilmore-Bykovskyi: None; K. Phelps: None; C. Bartels: Pfizer, 5.

To cite this abstract in AMA style:

Parikh S, Messina M, Garg S, Ferguson S, Ramly E, Gilmore-Bykovskyi A, Phelps K, Bartels C. Advancing Health Equity with Lupus Stakeholders to Close Care Gaps and Disparities [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/advancing-health-equity-with-lupus-stakeholders-to-close-care-gaps-and-disparities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/advancing-health-equity-with-lupus-stakeholders-to-close-care-gaps-and-disparities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology